Sermorelin vs Ipamorelin: Which peptide is right for you? NiceRx The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The FDA's Decision to Ban Compounds: What You Need to Know FDA approves Ipsen's Iqirvo 'to address unmet need' in primary biliary cholangitis